Alps Advisors Inc Day One Biopharmaceuticals, Inc. Transaction History
Alps Advisors Inc
- $14.5 Billion
- Q2 2024
A detailed history of Alps Advisors Inc transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 68,170 shares of DAWN stock, worth $940,746. This represents 0.01% of its overall portfolio holdings.
Number of Shares
68,170
Previous 61,631
10.61%
Holding current value
$940,746
Previous $1.02 Million
7.76%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding DAWN
# of Institutions
166Shares Held
71.7MCall Options Held
163KPut Options Held
183K-
Ra Capital Management, L.P. Boston, MA7.87MShares$109 Million1.63% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$88.7 Million11.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$63.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$62.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.78MShares$52.2 Million0.02% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.01B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...